[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 2573 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  1st Session
                                S. 2573

    To amend the Controlled Substances Act to prohibit the knowing 
possession of a pill press mold with intent to manufacture in violation 
 of such Act a counterfeit substance in schedule I or II in a capsule, 
    tablet, and other form intended for distribution, and for other 
                               purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           September 26, 2019

Mr. Cassidy (for himself and Ms. Hassan) introduced the following bill; 
  which was read twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
    To amend the Controlled Substances Act to prohibit the knowing 
possession of a pill press mold with intent to manufacture in violation 
 of such Act a counterfeit substance in schedule I or II in a capsule, 
    tablet, and other form intended for distribution, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Criminalizing Abused Substance 
Templates Act of 2019''.

SEC. 2. UNLAWFUL POSSESSION OF PILL PRESS MOLDS.

    (a) Prohibition.--Section 401 of the Controlled Substances Act (21 
U.S.C. 841) is amended by adding at the end the following:
    ``(i) Offense Regarding Unlawful Possession of Pill Press Molds.--
            ``(1) In general.--Whoever, with intent to manufacture in 
        violation of this title a counterfeit substance in schedule I 
        or II in a capsule, tablet, or other form for distribution, 
        knowingly possesses a pill press mold, shall be imprisoned not 
        more than 20 years and fined in accordance with title 18, 
        United States Code.
            ``(2) Definitions.--In this subsection, the term `pill 
        press mold' means any punch, die, plate, stone, or other object 
        designed to print, imprint, or reproduce on a controlled 
        substance (or the container or labeling thereof) the trademark, 
        trade name, or other identifying mark, imprint, number, or 
        device, or any likeness thereof, of a manufacturer, 
        distributor, or dispenser other than the person or persons who 
        in fact manufactured, created, distributed, or dispensed such 
        product, thereby rendering it a counterfeit substance.''.
    (b) Sentencing Guidelines.--Pursuant to its authority under section 
994 of title 28, United States Code, and in accordance with this 
section, the United States Sentencing Commission shall review and 
amend, as appropriate, the Federal sentencing guidelines and policy 
statements to ensure that the guidelines provide for a penalty 
enhancement of not less than 2 offense levels above the offense level 
otherwise applicable for a violation of section 401(a) of the 
Controlled Substances Act (21 U.S.C. 841(a)) if the defendant is found, 
in connection with such violation of section 401(a), to be in violation 
of section 401(i) of the Controlled Substances Act, as added by 
subsection (a).
                                 <all>